4
Views
5
CrossRef citations to date
0
Altmetric
Original Article

The Effect of Pain on Outcomes in a Trial of Duloxetine Treatment of Major Depressive Disorder

, , , , , & show all
Pages 187-193 | Published online: 04 Dec 2011

References

  • Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity. A literature review. Arch Intern Med 2003;1'63: 2433–2445.
  • Ohayon MM, Schatzberg AF. Using chronic pain to predict depres-sive morbidity in the general population. Arch Gen Psychiatry 2003;60:39–47.
  • Von Korff M, Ormel J, Katon W, Lin EHB. Disability and depres-sion among high utilizers of health care. A longitudinal analysis. Arch Gen Psychiatry 1992;49:91–100.
  • Ohayon MM. Specific characteristics of the pain/depression asso-ciation in the general population. J Clin Psychiatry 2004;65 [suppl 121:5–9.
  • Boa Y, Sturm R, Croghan TW. A national study of the effect of chronic pain on the use of health care by depressed persons. Psy-chiatr Serv 2003;54:693–697.
  • Greenberg PE, Leong SA, Birnbaum HG, Robinson RL. The economic burden of depression with painful symptoms. J Clin Psychiatry 2003;64[suppl 71:17–23.
  • Bair MJ, Robinson RL, Eckert GJ, Stang PE, Croghan TW, Kroenke K. Impact of pain on depression treatment response in primary care. Psychosom Med 2004;66:17–22.
  • Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995;25:1171–1180.
  • Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms results in higher remission rates? J Clin Psychiatry 2004;65:521–530.
  • Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA. Duloxetine in the treatment of major depressive disorder: a double-blind clin-ical trial. J Clin Psychiatry 2002;63:225–231.
  • Detke MJ, Goldstein DJ, Hayes JR, Demitrack MA. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 2002;63: 308–315.
  • Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res 2002;36: 383–390.
  • Goldstein DJ, Lu Y, Detke MJ, Hudson J, Iyengar S, Demitrack MA. Effects of duloxetine on painful physical symptoms associ-ated with depression. Psychosomatics 2004;45:17–28.
  • Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger Al, Iyengar S, Wernicke JF. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005;6:346–356.
  • Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116:109–118.
  • Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004; 50:2974–2984.
  • Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke IF. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005;119:5–15.
  • Wohlreich MM, Martinez JM, Mallinckrodt CH, Prakash A, Watkin JG, Fava M. An open-label study of duloxetine for the treatment of major depressive disorder. J Clin Psychopharmacol 2005;25:552–560.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56–62.
  • Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. US Department of Health, Education, and Welfare pub-lication (ADM). Rockville, MD: National Institute of Mental Health, 1976: 76–338.
  • Farrar if, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94: 149–158.
  • Millan MJ. Descending control of pain. Prog Neurobiol 2002; 66:355–474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.